References
- Suliga E, Wawszczak M, Gluszek S. The roles of vaspin, chemerin, and omentin in the determination of metabolic syndrome. Med Studies. 2018; 34(2): 160-177.10.5114/ms.2018.76878
- Feng R, Li Y, Wang C, Luo C, Liu L. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: A meta-analysis. Diabetes Res Clin Pract. 2014; 106(1): 88-94.2515122710.1016/j.diabres.2014.07.026
- Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 2011;12:60.
- Mahdirejei HA, Abadei SFR, Seidi AA, Eshaghei Gorji N, Rahmani Kafshgari H, Ebrahim Pour M, et al. Effects of an eight-week resistance training on plasma vaspin concentrations, metabolic parameters levels and physical fitness in patients with type 2 diabetes. Cell J. 2014; 16(3): 367-374.24611142
- Esteghamati A, Noshad S, Mousavizadeh M, Zandieh A, Nakhjavani M. Association of vaspin with metabolic syndrome: The pivotal role of insulin resistance. Diabetes Metabol J. 2014; 38(2): 143-149.10.4093/dmj.2014.38.2.143
- Alnory A, Gad H, Hegazy G, Shaker O. The association of vaspin rs2236242 and leptin rs7799039 polymorphism with metabolic syndrome in Egyptian women. Turkish J Med Sci. 2016; 46(5): 1335-1340.10.3906/sag-1502-138
- Hashemi M, Rezaei H, Eskandari-Nasab E, Kaykhaei MA, Zakeri Z, Taheri M. Association between chemerin rsl7173608 and vaspin rs2236242 gene poly-morphisms and the metabolic syndrome, a preliminary report. Gene. 2012; 510(2): 113-117.10.1016/j.gene.2012.08.048
- Mehanna ET, Mesbah NM, Ghattas MH, Saleh SM, Abo-Elmatty DM. Association of chemerin Rsl7173608 and vaspin Rs2236242 gene polymorphisms with metabolic syndrome in Egyptian women. Endocr Res. 2016; 41(1): 43-48.2647266310.3109/07435800.2015.1066802
- Suliga E, Koziel D, Cieśla Ε, Rebak D, Ghiszek S. Dietary patterns in relation to metabolic syndrome among adults in Poland: A cross-sectional study. Nutrients. 2017; 9(12): E1366.10.3390/nu9121366
- Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16):1640-1645.
- Kohan L, Zarei A, Fallahi S, Tabiee O. Association between vaspin rs2236242 gene polymorphism and polycystic ovary syndrome risk. Gene. 2014; 539(2): 209-212.10.1016/j.gene.2014.01.07824530312
- Abdel Ghany SM, Sayed AA, El-deek SEM, Elbadre HM, Dahpy MA, Saleh MA, et al. Obesity risk prediction among women of Upper Egypt: The impact of serum vaspin and vaspin rs2236242 gene polymorphism. Gene. 2017; 626(1): 140-148.10.1016/j.gene.2017.05.00728479386
- Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/ KORA studies. Exp Clin Endocrinol Diabetes. 2008; 118(3): 184-189.10.1055/s-2008-108149918726871
- Kilpeläinen TO, Qi L, Brage S, Sharp SJ, Sone-stedt E, Demerath E, et al. Physical activity attenuates the influence of FTO variants on obesity risk: A meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011; 8(11): el001116.
- Kilpeläinen TO, Franks PW. Gene-physical activity interactions and their impact on diabetes. Diabetes Phys Act. 2014; 60: 94-103.
- Abdullah MS, Verweij N, Van Der Harst P. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study. JAMA Cardiol. 2018; 3(8): 693-702.10.1001/jamacardio.2018.171729955826
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005; 112(17): 2735-2752.1615776510.1161/CIRCULATIONAHA.105.169404
- Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabil. 2018; 10: 7.10.1186/s13102-018-0097-129755739
- Brito EC, Lyssenko V, Renstrom F, Berglund G, Nilsson PM, Groop L, et al. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: A study of 16,003 Swedish adults. Diabetes. 2009; 58(6): 1411-1418.10.2337/db08-162319324937
- Graff M, Scott RA, Justice AE, Young KL, Feitosa MF, Barata L, et al. Genome-wide physical activity interactions in adiposity –A meta-analysis of 200,452 adults. PLoS Genet. 2017; 13(4): el006528.
- Hamer M, Chida Y. Walking and primary prevention: A meta-analysis of prospective cohort studies. Br J Sports Med. 2008; 42(4): 238-243.10.1136/bjsm.2007.03997418048441
- Kato Μ, Goto A, Tanaka T, Sasaki S, Igata A, Noda M. Effects of walking on medical cost: A quantitative evaluation by simulation focusing on diabetes. J Diabetes Invest. 2013; 4(6): 667-672.10.1111/jdi.12114
- Tajima M, Lee JS, Watanabe E, Park JS, Tsuchiya R, Fukahori A, et al. Association between changes in 12 lifestyle behaviors and the development of metabolic syndrome during 1 year among workers in the Tokyo Metropolitan area. Circ J. 2014; 78(5): 1152-1159.10.1253/circj.CJ-13-108224583972
- Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, Cho SG, et al. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clin Endocrinol. 2014; 80(6): 825-833.10.1111/cen.12249
- Zhang D, Liu X, Liu Y, Sun X, Wang B, Ren Y, et al. Leisure-time physical activity and incident metabolic syndrome: A systematic review and dose-response meta-analysis of cohort studies. Metabolism. 2017; 75: 36-44.2892773710.1016/j.metabol.2017.08.001